A Clinical Trial of TQC3927 Powder for Inhalation in Chronic Obstructive Pulmonary Disease
Status:
COMPLETED
Trial end date:
2025-08-11
Target enrollment:
Participant gender:
Summary
This project is the stage of dose escalation, is was divided into single and multiple dose clinical study, This is a multi-center, randomized, double-blind, placebo-controlled , study to the safety, tolerability and pharmacokinetic characteristics of TQC3927 powder for inhalation in Chronic Obstructive Pulmonary Disease